Fair Way Pharmaceuticals Private Limited

Product Description

A sterile, broad-spectrum carbapenem-class antibiotic provided as a 250 mg vial of Meropenem powder for IV/IM reconstitution. This high-grade injection is formulated for use in clinical and hospital environments, delivering potent bactericidal activity by inhibiting bacterial cell-wall synthesis against serious infections such as pneumonia, complicated skin and soft tissue infections, intra-abdominal infections, meningitis, sepsis, and febrile neutropenia. Meropenem offers flexible IV administration (bolus or infusion) and optimized dosing regimens—including adjustments for renal impairment—ensuring reliable therapeutic levels and patient compliance . It is distinguished by low protein binding (~2%), stability in biological fluids, and a comparatively favorable safety profile with reduced seizure risk versus imipenem. Merocode 250 is ideal for B2B procurement by hospitals, clinics, and healthcare distributors requiring a powerful, hospital-grade anti-infective solution.

Product Description

This sterile, cephalosporin-class antibiotic contains 250 mg of Cefuroxime Sodium per vial, designed for IV/IM administration in hospital and clinical environments. It offers broad-spectrum antibacterial action against respiratory, urinary, skin, bone/joint, and intra-abdominal infections, as well as surgical prophylaxis. With a dosing regimen of 750 mg–1.5 g every 8 hours (up to 3 g for meningitis every 8 hours), it ensures effective therapeutic levels and flexibility for both moderate and severe infections. Ideal for B2B distribution, Skynet 250 supports efficient infection control where rapid and reliable IV treatment is needed.

Product Description

This injectable combination of Cefepime, a fourth-generation cephalosporin, and Tazobactam, a β-lactamase inhibitor, offers broad-spectrum antibacterial activity, including against resistant gram-negative and gram-positive organisms. It is used in the treatment of severe bacterial infections such as pneumonia, urinary tract infections, intra-abdominal infections, and sepsis.